Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT
Crossref DOI link: https://doi.org/10.1007/s12253-017-0264-9
Published Online: 2017-07-06
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sienkiewicz, Beata
Urbaniak-Kujda, Donata
Dybko, Jarosław
Dryś, Andrzej
Hurkacz, Magdalena
Wróbel, Tomasz
Wiela-Hojeńska, Anna
Funding for this research was provided by:
Ministry of Science and Higher Education, Republic of Poland (ST-774)
License valid from 2017-07-06